Cargando…

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD

BACKGROUND: One in three patients hospitalised due to acute exacerbation of COPD (AECOPD) is readmitted within 90 days. No tool has been developed specifically in this population to predict readmission or death. Clinicians are unable to identify patients at particular risk, yet resources to prevent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Echevarria, C, Steer, J, Heslop-Marshall, K, Stenton, S C, Hickey, P M, Hughes, R, Wijesinghe, M, Harrison, R N, Steen, N, Simpson, A J, Gibson, G J, Bourke, S C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537524/ https://www.ncbi.nlm.nih.gov/pubmed/28235886 http://dx.doi.org/10.1136/thoraxjnl-2016-209298

Ejemplares similares

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD
por: Steer, John, et al.
Publicado: (2015)

Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score
por: Echevarria, Carlos, et al.
Publicado: (2019)

Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation
por: Echevarria, Carlos, et al.
Publicado: (2018)

Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
por: Wang, Ye, et al.
Publicado: (2023)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Specialist emergency care and COPD outcomes
por: Lane, Nicholas David, et al.
Publicado: (2018)

Interventions to standardise hospital care at presentation, admission or discharge or to reduce unnecessary admissions or readmissions for patients with acute exacerbation of chronic obstructive pulmonary disease: a scoping review
por: MacDonell, Rachel, et al.
Publicado: (2020)

Decreased capsaicin cough reflex sensitivity predicts hospitalisation due to COPD
por: Kanemitsu, Yoshihiro, et al.
Publicado: (2023)

Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD
por: Dicker, Alison J, et al.
Publicado: (2018)

Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
por: Stone, Philip W, et al.
Publicado: (2022)

Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study
por: Wang, Yuanyuan, et al.
Publicado: (2020)

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
por: Mayhew, David, et al.
Publicado: (2018)

Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
por: Stolbrink, Marie, et al.
Publicado: (2019)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Home-based pulmonary rehabilitation early after hospitalisation in COPD (early HomeBase): protocol for a randomised controlled trial
por: Cox, Narelle S, et al.
Publicado: (2021)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
por: Citgez, Emanuel, et al.
Publicado: (2021)

Smoking and socioeconomic factors linked to acute exacerbations of COPD: analysis from an Asthma + Lung UK survey
por: Williams, Parris J, et al.
Publicado: (2022)

Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD
por: Suh, Eui-Sik, et al.
Publicado: (2015)

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France
por: Whittaker, Hannah, et al.
Publicado: (2022)

Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease
por: Nishimura, Koichi, et al.
Publicado: (2018)

Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
por: Hitchings, Andrew W, et al.
Publicado: (2016)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation
por: Pal, Arijeet, et al.
Publicado: (2022)

Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study
por: McKeever, Tricia M, et al.
Publicado: (2016)

Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study
por: Morasert, Thotsaporn, et al.
Publicado: (2020)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
por: Søyseth, Vidar, et al.
Publicado: (2021)

Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials
por: Verstraete, Kenneth, et al.
Publicado: (2023)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
por: Blagev, Denitza P, et al.
Publicado: (2020)

Inter-relationships among neutrophilic inflammation, air trapping and future exacerbation in COPD: an analysis of ECOPD study
por: Yang, Huajing, et al.
Publicado: (2023)

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023)

Association between self-reported moderate to vigorous physical activity and the rate of outpatient treated COPD exacerbations: retrospective cohort study
por: Nguyen, Huong Q, et al.
Publicado: (2020)

COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD
por: Prins, Hendrik Johannes, et al.
Publicado: (2021)

Development of a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease
por: Ospina, Maria B, et al.
Publicado: (2018)

Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study
por: Lin, Shan-Ju, et al.
Publicado: (2023)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bdp98uo7ndklr2c8j65uef5mft